DK0728140T3 - Hidtil ukendte steroider med radikofile substituenter, fremgangsmåde til deres fremstilling og lægemidler indholdende disse forbindelser - Google Patents
Hidtil ukendte steroider med radikofile substituenter, fremgangsmåde til deres fremstilling og lægemidler indholdende disse forbindelserInfo
- Publication number
- DK0728140T3 DK0728140T3 DK95900069T DK95900069T DK0728140T3 DK 0728140 T3 DK0728140 T3 DK 0728140T3 DK 95900069 T DK95900069 T DK 95900069T DK 95900069 T DK95900069 T DK 95900069T DK 0728140 T3 DK0728140 T3 DK 0728140T3
- Authority
- DK
- Denmark
- Prior art keywords
- substituents
- methods
- radical
- compounds
- novel substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4338316A DE4338316A1 (de) | 1993-11-10 | 1993-11-10 | Neue Steroide mit radikophilen Substituenten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
PCT/DE1994/001310 WO1995013287A1 (de) | 1993-11-10 | 1994-11-08 | Neue steroide mit radikophilen substituenten, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0728140T3 true DK0728140T3 (da) | 2001-12-10 |
Family
ID=6502215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95900069T DK0728140T3 (da) | 1993-11-10 | 1994-11-08 | Hidtil ukendte steroider med radikofile substituenter, fremgangsmåde til deres fremstilling og lægemidler indholdende disse forbindelser |
Country Status (11)
Country | Link |
---|---|
US (2) | US5914325A (es) |
EP (1) | EP0728140B1 (es) |
JP (1) | JP2828780B2 (es) |
AT (1) | ATE205851T1 (es) |
AU (1) | AU8104294A (es) |
CA (1) | CA2176368A1 (es) |
DE (2) | DE4338316A1 (es) |
DK (1) | DK0728140T3 (es) |
ES (1) | ES2162906T3 (es) |
PT (1) | PT728140E (es) |
WO (1) | WO1995013287A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319914B1 (en) | 1993-11-05 | 2001-11-20 | Apollo Biopharmaceuticals, Inc. | Cytoprotective effect of polycyclic phenolic compounds |
US6327387B1 (en) | 1996-12-27 | 2001-12-04 | Fujitsu Limited | Apparatus and method for extracting management information from image |
DE19723794A1 (de) | 1997-06-06 | 1998-12-10 | Jenapharm Gmbh | Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität |
US6355630B1 (en) | 1997-10-23 | 2002-03-12 | American Home Products Corporation | Estra-1,3,5(10)-triene-7α-thioethers |
JP2001520235A (ja) * | 1997-10-23 | 2001-10-30 | アメリカン・ホーム・プロダクツ・コーポレイション | エストラ−1,3,5(10)−トリエン−7α−チオエーテル |
ATE361310T1 (de) * | 2000-11-03 | 2007-05-15 | Univ Washington | Östronderivate mit zellschützender wirkung |
AU2002228891A1 (en) * | 2000-11-17 | 2002-05-27 | Washington University | Cytoprotective estrogen derivatives |
CA2457142A1 (en) * | 2001-08-17 | 2003-02-27 | University Of Pittsburgh | Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
US8569275B2 (en) | 2002-08-28 | 2013-10-29 | Harbor Therapeutics, Inc. | Steroids having 7-oxgen and 17-heteroaryl substitution |
US9284345B2 (en) * | 2007-04-12 | 2016-03-15 | Endorecherche, Inc. | 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
RS58166B1 (sr) | 2013-03-13 | 2019-03-29 | Sage Therapeutics Inc | Neuroaktivni steroidi i postupci za njihovu upotrebu |
PT3436022T (pt) | 2016-04-01 | 2022-07-04 | Sage Therapeutics Inc | Oxisteróis e métodos de utilização dos mesmos |
US10752653B2 (en) | 2016-05-06 | 2020-08-25 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
MA45598B1 (fr) | 2016-07-07 | 2021-09-30 | Sage Therapeutics Inc | Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda |
AU2017337121B2 (en) | 2016-09-30 | 2022-01-27 | Sage Therapeutics, Inc. | C7 substituted oxysterols and methods as NMDA modulators |
EP4105223A1 (en) | 2016-10-18 | 2022-12-21 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3193564A (en) * | 1964-01-27 | 1965-07-06 | Searle & Co | 17alpha-(aralkyl)estra-1, 3, 5(10)-triene-3, 17beta-diols, intermediates thereto, and esters corresponding |
GB1076962A (en) * | 1965-02-25 | 1967-07-26 | British Drug Houses Ltd | Steroidal 6-substituted-methyl-4,6-dien-3-ones |
DE2247390A1 (de) * | 1972-09-27 | 1974-03-28 | Merck Patent Gmbh | Neue 1-alkylthio-androstan-derivate |
FR2407940A1 (fr) * | 1977-11-08 | 1979-06-01 | Roussel Uclaf | Nouveaux derives steroides 17 a-aryle, ou 17 a-heteroaryle, leur procede de preparation et leur application comme medicament |
FR2640977A2 (en) * | 1982-06-11 | 1990-06-29 | Roussel Uclaf | New position-11 substituted 19-norsteroids and their application as medicinal products. |
WO1987001706A2 (en) * | 1985-09-12 | 1987-03-26 | The Upjohn Company | C20 through c26 amino steroids |
US5371078A (en) * | 1988-10-31 | 1994-12-06 | Alcon Laboratories, Inc. | Angiostatic steroids and methods and compositions for controlling ocular hypertension |
FR2644789B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
FR2644788B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
FR2644787B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
DE4000397A1 (de) * | 1990-01-09 | 1991-07-11 | Hoechst Ag | Lipidselektive antioxidantien sowie deren herstellung und verwendung |
AU642711B2 (en) * | 1990-01-26 | 1993-10-28 | Upjohn Company, The | 5-oxygenated-2,4,6-triaminopyrimidines |
DE4312034A1 (de) * | 1993-04-13 | 1994-10-20 | Hesch Rolf Dieter Prof Dr Med | Neuartige Androgene und Anabolika |
-
1993
- 1993-11-10 DE DE4338316A patent/DE4338316A1/de not_active Withdrawn
-
1994
- 1994-11-08 ES ES95900069T patent/ES2162906T3/es not_active Expired - Lifetime
- 1994-11-08 DK DK95900069T patent/DK0728140T3/da active
- 1994-11-08 AT AT95900069T patent/ATE205851T1/de not_active IP Right Cessation
- 1994-11-08 US US08/646,252 patent/US5914325A/en not_active Expired - Fee Related
- 1994-11-08 EP EP95900069A patent/EP0728140B1/de not_active Expired - Lifetime
- 1994-11-08 WO PCT/DE1994/001310 patent/WO1995013287A1/de active IP Right Grant
- 1994-11-08 CA CA002176368A patent/CA2176368A1/en not_active Abandoned
- 1994-11-08 JP JP7513528A patent/JP2828780B2/ja not_active Expired - Fee Related
- 1994-11-08 PT PT95900069T patent/PT728140E/pt unknown
- 1994-11-08 DE DE59409872T patent/DE59409872D1/de not_active Expired - Lifetime
- 1994-11-08 AU AU81042/94A patent/AU8104294A/en not_active Abandoned
-
1999
- 1999-02-20 US US09/253,650 patent/US5977096A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0728140A1 (de) | 1996-08-28 |
ATE205851T1 (de) | 2001-10-15 |
JPH09507471A (ja) | 1997-07-29 |
PT728140E (pt) | 2002-02-28 |
US5914325A (en) | 1999-06-22 |
US5977096A (en) | 1999-11-02 |
DE4338316A1 (de) | 1995-05-11 |
JP2828780B2 (ja) | 1998-11-25 |
AU8104294A (en) | 1995-05-29 |
EP0728140B1 (de) | 2001-09-19 |
DE59409872D1 (de) | 2001-10-25 |
ES2162906T3 (es) | 2002-01-16 |
CA2176368A1 (en) | 1995-05-18 |
WO1995013287A1 (de) | 1995-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0728140T3 (da) | Hidtil ukendte steroider med radikofile substituenter, fremgangsmåde til deres fremstilling og lægemidler indholdende disse forbindelser | |
DK0775156T3 (da) | Farmaceutiske sammensætninger med estra-1,3,5(19)-trien-derivater | |
AU717116B2 (en) | Steroid sulphatase inhibitors | |
DK1090029T3 (da) | 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser | |
ES2276463T3 (es) | Sulfamato de esteroide, procedimiento para su preparacion y su utilizacion. | |
NO20061455L (no) | 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse | |
AU2560584A (en) | Protein compositions substantially free from infectious agents | |
NO950774L (no) | Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol | |
NO303338B1 (no) | 17-spirometylen-steroider, farmas÷ytiske preparater inneholdende disse, og anvendelse av dem | |
US4994481A (en) | Treatment of AIDS with diphenylhydantoin and its derivatives | |
NO971789L (no) | Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler | |
DK282784D0 (da) | 1-alkyl-androsta-1,4-dien-3,17-dioner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem | |
IL81008A0 (en) | 10beta-alkynylestrene derivatives,their preparation and pharmaceutical compositions containing them | |
DK1322660T3 (da) | 17a-fluoralkylsteroider, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder disse forbindelser | |
Selye et al. | Protection by steroids against acute HgCl 2 poisoning | |
Maschler et al. | Ovarian enzymatic divergence in patients with polycystic ovary syndrome excreting urinary pregnanetriolone | |
DK164173C (da) | 6-substituerede androsta-1,4-dien-3,17-dionderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende saadanne forbindelser | |
HUP0301332A2 (hu) | Új mono- és biszmetilén-szteroid-származékok és eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
AU726811B2 (en) | Steroid sulphatase inhibitors | |
DK1090028T3 (da) | Umættede 14,15-cyclopropano-androstaner, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser | |
Kahri et al. | Effects of 5-bromodeoxyuridine on the ACTH-dependent mitochondrial biogenesis in cortical cells of fetal rat adrenals in tissue culture. | |
AU723707B2 (en) | Steroid sulphatase inhibitors | |
Tandon et al. | Use of ursodeoxycholic acid in liver diseases. | |
Poulson et al. | The antagonism by DON of growth induced by steroid hormones | |
BR0212826A (pt) | Método de redução da proteìna de transferência dos ésteres colesterìlicos mediada pela proteìna de transferência do éster do colesterol in vivo entre as lipoproteìnas de alta densidade (hdl) e lipoproteìnas de baixa densidade (ldl) |